Patent · US Active

Ketoreductase mutant and application thereof

US11162081B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 22, 2018
Grant dateNov 2, 2021
Priority date
Expiry dateJan 22, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A ketoreductase mutant and use thereof are provided. The amino acid sequence of the ketoreductase mutant is an amino acid sequence obtained by mutation of the amino acid sequence shown in SEQ ID NO: 1, wherein the mutation at least comprises one of the following mutation sites: position 6, position 94, position 96, position 117, position 144, position 156, position 193, position 205, position 224, position 176, position 85 and position 108; alternatively, the amino acid sequence of the ketoreductase mutant has a mutation site in a mutated amino acid sequence and an amino acid sequence having 80% or more homology with the mutated amino acid sequence.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.